全球更年期治療市場按治療類型、給藥途徑、劑型、適應症、通路和地區分類

預計 2025 年全球更年期治療市場規模為 152.3 億美元，到 2032 年將達到 230.5 億美元，2025 年至 2032 年的複合年成長率為 6.1%。

數字。 2025年全球市場佔有率（%）

閉經是自然的生物過程，通常發生在45至55歲之間的女性身上。更年期標誌著女性生育年齡的結束和生育後生活的過渡。更年期最常見的徵兆和症狀包括月經不規則、潮熱、盜汗、陰道乾燥、情緒變化和睡眠困難。隨著女性進入更年期，其雌激素水平會急劇下降。因此，控制這段過渡時期的症狀是許多女性的首要任務。全球更年期治療市場為遭受更年期症狀困擾的女性提供了各種治療選擇。

市場動態：

由於生活方式的改變和健康意識的增強，女性更年期症狀的盛行率不斷上升，這是推動全球更年期治療市場成長的主要因素。大量調查顯示，大約四分之一的40至60歲女性表示經歷過至少一種與更年期相關的問題症狀。久坐工作的出現和缺乏身體活動也會增加閉經的風險。此外，大型製藥企業核准和推出的新產品正在擴大治療更年期血管舒縮症狀的治療選擇。然而，荷爾蒙補充療法的副作用和替代治療方案的可用性仍然在一定程度上限制了市場潛力。此外，開發中國家對這種治療方法缺乏認知也為市場相關人員帶來了挑戰。然而，亞太地區更年期護理技術的進步和日益成長的醫療旅遊業預計將在未來幾年為相關人員提供豐厚的機會。

本研究的主要特點

• 本報告對全球更年期治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)。
• 它還揭示了不同領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球更年期治療市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行分析。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球更年期治療市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球更年期治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 新產品發布
  • 人口老化加劇
  • 透過贈款資助和投資提供財政支持
• 影響分析
• 主要亮點
• 市場趨勢
• PEST分析
• 監管情景
• 合併、收購和合作
• 主要提供的服務
• 治療成本分析
• 識別頂級市場參與者
• 政府措施和投資
• 品牌映射和定價分析
• 各國醫療保健支出

4. 全球更年期治療市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020 年至 2032 年全球更年期治療市場（依治療類型分類）

• 荷爾蒙療法
• 雌激素類藥物
• 黃體素
• 合併用藥（雌激素和黃體素、雌激素和另一種藥物）
• 非荷爾蒙療法
• 神經激肽 3 (NK3)
• 受體拮抗劑
• 選擇性血清素
• 再回收抑制劑（SSRI）
• 其他
• 其他

6. 全球更年期治療市場（依給藥途徑分類），2020 年至 2032 年

• 口服
• 外用
• 腸外
• 陰道
• 其他

7. 2020 年至 2032 年全球更年期治療市場（以劑型分類）

• 錠劑
• 奶油
• 修補
• 子宮托
• 注射
• 其他

8. 全球更年期治療市場（依適應症分類），2020 年至 2032 年

• 停經
• 閉經
• 停經後

9. 2020 年至 2032 年全球更年期治療市場（依通路分類）

• 醫院藥房
• 零售藥局
• 網路藥局
• 專賣店
• 其他

第 10 章。 2020 年至 2032 年按地區分類的全球更年期治療市場

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第11章競爭格局

• 公司簡介
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck &Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • SnapNurse
  • Glenmark Pharmaceuticals Limited
  • Procter &Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.

第12章 章節

• 參考
• 調查方法
• 關於出版商

Global Menopause Treatment Market is estimated to be valued at USD 15.23 Bn in 2025 and is expected to reach USD 23.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Figure. Global Menopause Treatment Market Share (%), By Region 2025

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

• Global Menopause Treatment Market, By Treatment Type
  • Hormone Therapy
  • Estrogen-based Drugs
  • Progestin-based Drugs
  • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
  • Non-hormonal Therapy
  • Neurokinin 3 (NK3)
  • Receptor Antagonist
  • Selective Serotonin
  • Reuptake Inhibitor (SSRI)
  • Others
  • Others
• Global Menopause Treatment Market, By Route of Administration
  • Oral
  • Topical
  • Parenteral
  • Vaginal
  • Others
• Global Menopause Treatment Market, By Form
  • Tablets
  • Creams
  • Patches
  • Pessaries
  • Injections
  • Others
• Global Menopause Treatment Market, By Indication
  • Perimenopause
  • Menopause
  • Postmenopause
• Global Menopause Treatment Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Stores
  • Others
• Global Menopause Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck & Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • Glenmark Pharmaceuticals Limited
  • Procter & Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Treatment Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Form
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • New Product Launches
  • Rising Geriatric Population
  • Financial Support Through Funding And Investments
• Impact Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• Regulatory Scenario
• Mergers, Acquisitions, and Collaborations
• Key Services Offered
• Treatment cost Analysis
• Identification of Top Market Players
• Government Initiatives and Investments
• Brand Mapping & Pricing Analysis
• Healthcare Spending by Country

4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Menopause Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hormone Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Estrogen-based Drugs
• Progestin-based Drugs
• Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
• Non-hormonal Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neurokinin 3 (NK3)
• Receptor Antagonist
• Selective Serotonin
• Reuptake Inhibitor (SSRI)
• Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Menopause Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Menopause Treatment Market, By Form, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pessaries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Menopause Treatment Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Perimenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Menopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Postmenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Menopause Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Specialty Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Menopause Treatment Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region/Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region/Country, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

11. Competitive Landscape

• Company Profile
  • Novartis AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck & Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • SnapNurse
  • Glenmark Pharmaceuticals Limited
  • Procter & Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.
• Analyst Views

12. Section

• References
• Research Methodology
• About us